2026 NPPES data Hematology & Oncology Physician NPI 1528228921 M.D.
Verify on CMS →

NIHAR PATEL, M.D.

Hematology & Oncology Physician in ROUND ROCK, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
614
Medicare Part D claims · 149 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
78%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.4449/100
▲ 6 pts above national avg 83.1 · [object Object]
Industry payments
$18.6K
26 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NIHAR PATEL, M.D. reported a CMS MIPS final score of 89.4449/100 — above the 83.1 national average — and filed 614 Medicare Part D claims in 2023.

89.4449/100
MIPS score · +6 vs avg
614
Part D claims, 2023
78%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NIHAR PATEL, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

89 Top 42% higher than 58% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NIHAR PATEL, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NIHAR PATEL, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 06/10/2008

NPI 1528228921

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

614 28% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

89.4449/100 6.34490000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Texas

How Hematology & Oncology Physician compares to other specialties among Texas providers

Texas providers

Hematology & Oncology Physician share within Texas

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Texas

Medicare quality performance — MIPS

NIHAR PATEL, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
89.4449/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 89.4449/100 vs national avg 83.1

0%100%National avg83%89.4%
MIPS final score (Hematology & Oncology Physician) — 89.4449/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NIHAR PATEL, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 2410 ROUND ROCK AVE STE 250, ROUND ROCK, TX, 78681, with a listed phone of (512) 341-8724. NPI 1528228921 was issued on 06/10/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PATEL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 614 prescription claims written by this provider, covering 149 Medicare beneficiaries and totaling roughly $423K in drug spend, split 22% brand-name and 78% generic by claim count, with an opioid prescribing rate of 12.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.4449/100 for the 2023 performance year (Quality 75.8575), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2410 ROUND ROCK AVE STE 250
ROUND ROCK, TX 78681

Provider Details

NPI 1528228921
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 06/10/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

89.4449
Final Score
Avg: 83.1
75.8575
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where NIHAR PATEL, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

TEXAS ONCOLOGY PA
ROUND ROCK, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NIHAR PATEL, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$18.6K

Largest payer

Daiichi Sankyo Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to NIHAR PATEL, M.D.. To verify NIHAR PATEL, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

NIHAR PATEL, M.D. — brand share 22.0%
Specialty average (est.)

22% brand-name claims vs 78% generic, on 614 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

614
Total Claims
$423K
Total Drug Cost
149
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
850
Total Day Supply
21,753
Brand vs Generic
22% brand / 78% generic
Brand Drug Cost
$413K
Generic Drug Cost
$10K
Opioid Claims
77 (12.5% rate)
Antibiotic Claims
23

Patient Demographics

Average Patient Age
72.8 years
Avg HCC Risk Score
1.70
Gender Split
50% female / 50% male
Age Distribution
<65: 12, 65-74: 72, 75-84: 46, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NIHAR PATEL, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Eliquis
Apixaban
67
Xarelto
Rivaroxaban
31
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
30
Ondansetron Odt
Ondansetron
28
Ondansetron Hcl
26
Acyclovir
25
Letrozole
24
Furosemide
23
Prednisone
23
Dexamethasone
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How NIHAR PATEL, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

NIHAR PATEL, M.D.'s 614 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as PATEL.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NIHAR PATEL, M.D.'s specialty?
NIHAR PATEL, M.D. specializes in Hematology & Oncology Physician and practices in ROUND ROCK, Texas. Credentials: M.D..
How much does NIHAR PATEL, M.D. prescribe under Medicare Part D?
In 2023, NIHAR PATEL, M.D. wrote 614 Medicare Part D claims totaling $423K in drug costs for 149 beneficiaries.
What is NIHAR PATEL, M.D.'s Medicare quality score?
NIHAR PATEL, M.D. has a CMS MIPS Final Score of 89.4449/100 (Quality: 75.8575). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NIHAR PATEL, M.D. located?
NIHAR PATEL, M.D. is located at 2410 ROUND ROCK AVE STE 250, ROUND ROCK, TX, 78681. Phone: (512) 341-8724.
What is NIHAR PATEL, M.D.'s NPI number?
NIHAR PATEL, M.D.'s National Provider Identifier (NPI) is 1528228921, issued on 06/10/2008.
Does NIHAR PATEL, M.D. prescribe more brand-name or generic drugs?
NIHAR PATEL, M.D.'s prescribing is 22% brand-name and 78% generic drugs by claim count, with $413K in brand drug costs.
Does NIHAR PATEL, M.D. prescribe opioids?
Yes, NIHAR PATEL, M.D. had 77 opioid claims in 2023 with an opioid prescribing rate of 12.5%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does NIHAR PATEL, M.D. prescribe most often?
Based on 2023 Medicare Part D data, NIHAR PATEL, M.D.'s most frequently prescribed drugs include Eliquis, Xarelto, Hydrocodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NIHAR PATEL, M.D. accept Medicare?
NIHAR PATEL, M.D. appears in CMS Medicare data with 614 Part D claims and 149 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NIHAR PATEL, M.D.'s credentials?
NIHAR PATEL, M.D.'s NPI is 1528228921 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology